Patent Assignment
Reel/Frame 052802/0899
Assignment of Assignor's Interest
Recorded: 2020-06-01
Pages: 4
Assignor
OESTERGAARD, MIKKEL ZAHLE
Executed: 2017-11-23
Assignee
F. HOFFMANN-LA ROCHE AG
GRENZACHERSTRASSE 124, BASEL, 4070, SWITZERLAND
Covered Property
(1)
Obinutuzumab Treatment of a Dlbcl Patient Subgroup
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 1, 2020
From: F. HOFFMANN-LA ROCHE AG
To: HOFFMANN-LA ROCHE INC.
Reel/Frame 052802/0910 →
Security Interest
Nov 7, 2023
From: NANOSTRING TECHNOLOGIES, INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 065490/0058 →
Security Interest
Feb 8, 2024
From: NANOSTRING TECHNOLOGIES, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 066528/0634 →
Release of Security Interest
May 16, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
To: NANOSTRING TECHNOLOGIES, INC.
Reel/Frame 067453/0565 →
Release of Security Interest
May 16, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: NANOSTRING TECHNOLOGIES, INC.
Reel/Frame 067453/0577 →
Assignment of Assignor's Interest
May 16, 2024
From: NANOSTRING TECHNOLOGIES, INC.
To: BRUKER SPATIAL BIOLOGY, INC.
Reel/Frame 067932/0109 →